Episode Details
Back to Episodes
Pharmaceutical Executive Daily: September 26, 2025
Published 7 months, 3 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover the White House’s push for a Most Favored Nation drug pricing model, the FDA’s approval of Eli Lilly’s Inluriyo for ESR1-mutated metastatic breast cancer, and President Trump’s call for steep tariffs on branded pharmaceuticals